• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带致病性 SMARCE1 变异的个体进行遗传咨询和筛查的重要性:一项家系研究。

The importance of genetic counseling and screening for people with pathogenic SMARCE1 variants: A family study.

机构信息

Consultant Neurosurgeon, Department of Neurosurgery, Barking Havering and Redbridge University Hospitals NHS Trust, UK.

Consultant neurosurgeon, Department of neurosurgery, Salford Royal Hospital, Manchester, UK.

出版信息

Am J Med Genet A. 2021 Feb;185(2):561-565. doi: 10.1002/ajmg.a.61970. Epub 2020 Nov 13.

DOI:10.1002/ajmg.a.61970
PMID:33185983
Abstract

Clear cell meningioma (CCM) is a rare variant of meningioma. In recent years, an association between cranial and spinal CCMs and germline loss of function mutations in the SMARCE1 gene (SWI/SNF chromatin remodeling complex subunit gene) has been discovered. We report a family with an incidental large spinal clear cell meningioma in a young adult following reflex screening for a germline loss of function pathogenic variant (PV) in the SMARCE1 gene. The index patient's mother and maternal grandfather were both also tested positive presymptomatically for SMARCE1. His mother developed intracranial and spinal meningiomas and his maternal grandfather developed a spinal CCM 4 years following a clear spinal MRI scan which required surgical excision. In this report we particularly emphasize the importance of genetic counseling and screening in siblings, parents and offspring of patients who are diagnosed with intracranial or spinal CCM in the context of SMARCE1 PVs. We recommend brain and spine Imaging screening of asymptomatic SMARCE1 PV carriers at least every 3 years, even if the baseline scan did not show any tumors.

摘要

透明细胞脑膜瘤(CCM)是脑膜瘤的一种罕见变体。近年来,颅脊 CCM 与胚系 SMARCE1 基因(SWI/SNF 染色质重塑复合物亚基基因)功能丧失突变之间的关联已被发现。我们报告了一个家族,一名年轻的成年患者在反射性筛查 SMARCE1 基因胚系功能丧失致病性变异(PV)时偶然发现了一个大的脊髓透明细胞脑膜瘤。该患者的母亲和外祖父在出现症状前均检测到 SMARCE1 呈阳性。他的母亲后来同时发展出颅内和脊髓脑膜瘤,而他的外祖父在脊髓 MRI 扫描显示正常 4 年后发展出脊髓 CCM,需要手术切除。在本报告中,我们特别强调了在患者被诊断为颅内或脊髓 CCM 时,对兄弟姐妹、父母和子女进行遗传咨询和筛查的重要性,这些患者的 SMARCE1 存在 PV。我们建议对无症状的 SMARCE1 PV 携带者进行脑和脊柱成像筛查,至少每 3 年一次,即使基线扫描未显示任何肿瘤。

相似文献

1
The importance of genetic counseling and screening for people with pathogenic SMARCE1 variants: A family study.携带致病性 SMARCE1 变异的个体进行遗传咨询和筛查的重要性:一项家系研究。
Am J Med Genet A. 2021 Feb;185(2):561-565. doi: 10.1002/ajmg.a.61970. Epub 2020 Nov 13.
2
Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.生殖系SMARCE1突变易导致脊髓和颅部透明细胞脑膜瘤。
J Pathol. 2014 Dec;234(4):436-40. doi: 10.1002/path.4427. Epub 2014 Oct 6.
3
A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening.一种与SMARCE1相关的遗传性脑膜瘤,对随访和家族筛查具有重要意义。
Neurogenetics. 2016 Apr;17(2):83-9. doi: 10.1007/s10048-015-0472-y. Epub 2016 Jan 23.
4
Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case.与SMARCE1种系突变相关的小儿颅内透明细胞脑膜瘤:1例新病例
Childs Nerv Syst. 2015 Mar;31(3):441-7. doi: 10.1007/s00381-014-2558-5. Epub 2014 Sep 24.
5
SMARCE1-related meningiomas: A clear example of cancer predisposing syndrome.SMARCE1 相关脑膜瘤:癌症易患综合征的明确例证。
Eur J Med Genet. 2023 Jul;66(7):104784. doi: 10.1016/j.ejmg.2023.104784. Epub 2023 May 8.
6
SMARCE1 mutation screening in classification of clear cell meningiomas.SMARCE1 突变筛选在透明细胞脑膜瘤分类中的应用。
Histopathology. 2017 Apr;70(5):814-820. doi: 10.1111/his.13135. Epub 2017 Feb 2.
7
SMARCE1 mutations in pediatric clear cell meningioma: case report.小儿透明细胞型脑膜瘤中的SMARCE1突变:病例报告
J Neurosurg Pediatr. 2015 Sep;16(3):296-300. doi: 10.3171/2015.3.PEDS14417. Epub 2015 Jun 26.
8
Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations.NF2 和 SMARCE1 突变相关儿童颅中窝脑膜瘤。
Ann Diagn Pathol. 2020 Jun;46:151516. doi: 10.1016/j.anndiagpath.2020.151516. Epub 2020 Apr 13.
9
Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.SMARCE1 表达缺失是透明细胞脑膜瘤的特异性诊断标志物:全面的免疫表型和分子分析。
Brain Pathol. 2018 Jul;28(4):466-474. doi: 10.1111/bpa.12524. Epub 2017 Jun 12.
10
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.透明细胞脑膜瘤的特征是具有高度独特的 DNA 甲基化谱和 SMARCE1 突变。
Acta Neuropathol. 2021 Feb;141(2):281-290. doi: 10.1007/s00401-020-02247-2. Epub 2020 Dec 14.

引用本文的文献

1
Clinical Presentation and Management of Atypical Meningioma in a Five-Year-Old Child: A Case Report.一名五岁儿童非典型脑膜瘤的临床表现与治疗:病例报告
Cureus. 2025 Jul 26;17(7):e88804. doi: 10.7759/cureus.88804. eCollection 2025 Jul.
2
Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors.癌症易感性综合征的最新进展及儿童脑肿瘤监测指南。
Clin Cancer Res. 2024 Jun 3;30(11):2342-2350. doi: 10.1158/1078-0432.CCR-23-4033.
3
Central nervous system clear cell meningioma: a systematic literature review.
中枢神经系统透明细胞脑膜瘤:系统文献回顾。
Neurosurg Rev. 2024 Jan 6;47(1):35. doi: 10.1007/s10143-023-02251-6.
4
Pediatric meningiomas: A literature review and diagnostic update.小儿脑膜瘤:文献综述与诊断进展
Neurooncol Adv. 2023 Jun 3;5(Suppl 1):i105-i111. doi: 10.1093/noajnl/vdac165. eCollection 2023 May.
5
SMARCE1 deficiency generates a targetable mSWI/SNF dependency in clear cell meningioma.SMARCE1 缺失在透明细胞脑膜瘤中产生可靶向的 mSWI/SNF 依赖性。
Nat Genet. 2022 Jun;54(6):861-873. doi: 10.1038/s41588-022-01077-0. Epub 2022 Jun 9.